REGULATORY SUPPORT • Drug delivery devices • Pharmaceutical packaging • Medical equipment KEY CHARACTERISTICS • Manufactured at four ISO 13485 certified sites, providing global consistency and increased security of supply • Documented change control beyond CAS number level, reducing the risk of change • Allows crystallization in semi-crystalline polymers to begin faster and complete earlier REGULATORY SUPPORT • Raw materials tested to: - ISO 10993-1 and USP biological evaluation - European Pharmacopeia 3.1.3/3.1.5 (polyolefin) - USP (polyethylene) - ICH Q3D elemental impurities • Registered Drug Master File (Type III) and/or Device Master File • Food contact established with FDA/EU* APPLICATION BULLETIN * FDA/EU compliance information available upon request Healthcare use limitations apply—see below.

Avient offers complete and flexible solutions to fulfill technical requirements and local standards.

No. 0514.02) Revised 09/21/2021 Page 1 of 2 SCOPE OF ACCREDITATION TO ISO/IEC 17025:2017 POLYMER DIAGNOSTICS INC. 33587 Walker Road Avon Lake, OH 44012 Ana De La Ree Phone: 440-930-3271 CHEMICAL Valid To: December 31, 2021 Certificate Number: 0514.02 In recognition of the successful completion of the A2LA evaluation process, accreditation is granted to this laboratory to perform the following rubber and plastics tests: Test Description: Test Method or Standard: Analysis of Volatile Contaminants from Polymers (Chromatography) VDA 277 FTIR (Fourier Transform Infrared) Spectroscopy ASTM E1252 (Except 7.6, 11.2, and 11.4) Flammability Horizontal Burn of Self-Supporting Plastics ASTM D635; UL 94; IEC 60695-11-10 Horizontal Burn of Materials Used in Occupant Compartments of Motor Vehicles ASTM D5132; FMVSS 302 (49 CFR 571.302); ISO 3785 Vertical Burn, 20 mm ASTM D3801; UL 94; IEC 60695-11-10 Vertical Burn, 125 mm ASTM D5048; UL 94; IEC 60695-11-20 Oxygen Index ASTM D2863 FT1 Flame Test UL1581, Clause 1060; UL2556/CSA C22.2 No 2556, Clause 9.3 Cable Flame Test UL1581, Clause 1061 VW1 Flame Test UL1581, Clause 1080; UL2556/CSA C22.2 No 2556, Clause 9.4 FT2/FH Flame Test UL1581, Clause 1100; UL2556/CSA C22.2 No 2556, Clause 9.1 FV-1 Flame Test UL1581, Clause 1060; UL2556/CSA C22.2 No 2556, Clause 9.5 Thin Material Burning Test UL-94 Glow Wire Test IEC 60695 2-10, 2-11, 2-12, 2-13 RVCM in PVC ASTM D4443 (A2LA Cert.

Just a few months ago, we completed the acquisition of the Clariant Masterbatch business, the largest acquisition in the 20-year history of our company. These investments also consider our global footprint, and we are positioned very well and strategically from a regional perspective. 8 Growth Drivers 2020 Revenue ($ Millions) Long-Term Growth Rate Sustainable Solutions $ 560 8–12% Healthcare 555 8–10% Composites / 5G 212 10% Growth in Emerging Regions 672 5% Other (GDP growth) 1,784 2–3% Pro Forma Avient $ 3,783 6.5% 2020 PE RF O RM AN CE 2020 HIGHLIGHTS 10 • Completed transformational Clariant Masterbatch acquisition and created new brand name Avient • Increased pro forma adjusted EPS 11% from $1.74 to $1.93 as an essential supplier during the pandemic and due to growth in demand for consumer applications • Specialty Engineered Materials delivered record operating income on gains from composites • Achieved record free cash flow, increased dividend for 10th year in a row and delevered from 3.5x to 2.7x net debt to pro forma adjusted EBITDA • Culture is everything: Certified as a Great Place to Work® $133 $150 2019PF 2020PF 10% 23%8% 21% 4% 15% 2006 2020PF Healthcare Consumer Packaging Avient Portfolio Transformation 22% 59% CLARIANT MASTERBATCH: TRANSFORMATIONAL ACQUISITION 11 Clariant MB EBITDA Growth Purchase Price Multiple 10.8 9.6 6.5 2019PF 2020PF 2020PF w/ Full Synergies x x x • Acquisition of Clariant Masterbatch significantly expands presence in healthcare, packaging and consumer end markets • Strength of portfolio – 13% EBITDA growth as an essential supplier in COVID response and recovery • Acquisition completed on July 1, 2020 for $1.4 billion. Our free cash flow supports shareholder value creation through investing in R&D for organic growth, completing bolt-on acquisitions, and returning cash to shareholders via our dividend program and opportunistic share repurchases. 25 1.

Ordinary administrative expenses of the Audit Committee that are necessary or appropriate in carrying out its duties While the Audit Committee has the responsibilities and powers set forth in this Charter, it is not the duty of the Audit Committee to plan or conduct audits or to determine that the Company’s financial statements and disclosures are complete and accurate and are in accordance with generally accepted accounting principles and applicable rules and regulations. The Audit Committee, after consultation with management, the independent auditor and others as the committee deems appropriate, shall make the final decision to restate previously issued financial statements, if necessary, because of an error in such financial statements as addressed in Accounting Principles Board Opinion No. 20 (APB Opinion No 20) or shall make the decision to disclose or take actions to prevent future reliance on a previously issued audit report or completed interim review related to previously issued financial statements based upon notification or advisement by its independent auditor.

No Did the facility complete any pollution prevention activities in the current NPRI reporting year No Report Submission and Electronic Certification NPRI ­ Electronic Statement of Certification Specify the language of correspondence English Comments (optional) I hereby certify that I have exercised due diligence to ensure that the submitted information is true and complete.

In 2019, Avient associates completed over 30,000 hours of training through these various delivery methods. Last year we completed the pre-registration for Korea REACH (K-REACH). Last year we completed the pre- registration for Korea REACH (K-REACH).

In 2019, Avient associates completed over 30,000 hours of training through these various delivery methods. Last year we completed the pre-registration for Korea REACH (K-REACH). Last year we completed the pre- registration for Korea REACH (K-REACH).

On January 3, 2017, the Company completed the acquisition of SilCoTec, Inc. On January 3, 2017, the Company completed the acquisition of SilCoTec, Inc. On January 3, 2017, the Company completed the acquisition of SilCoTec, Inc.

This procedure was completed by placing one 1/2 inch section of rayon gauze at the apex of each bar, and soaking the gauze with the disinfectant to saturate the material.